Kate Dellorusso
Stock Analyst at LifeSci Capital
(0.54)
# 4,038
Out of 4,421 analysts
18
Total ratings
40%
Success rate
-11.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kate Dellorusso
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACRS Aclaris Therapeutics | Initiated Coverage: Buy | $13 | $4.50 | +188.89% | 1 | Jun 1, 2026 | |
| UPB Upstream Bio | Maintained: Buy | $42 | $6.25 | +572.00% | 11 | May 19, 2026 | |
| MREO Mereo BioPharma Group | Maintained: Hold | n/a | $0.3094 | - | 2 | May 12, 2026 | |
| CRNX Crinetics Pharmaceuticals | Rated: Buy | $90 → $89 | $35.87 | +148.12% | 4 | May 9, 2026 |
Aclaris Therapeutics
Jun 1, 2026
Initiated Coverage: Buy
Price Target: $13
Current: $4.50
Upside: +188.89%
Upstream Bio
May 19, 2026
Maintained: Buy
Price Target: $42
Current: $6.25
Upside: +572.00%
Mereo BioPharma Group
May 12, 2026
Maintained: Hold
Price Target: n/a
Current: $0.3094
Upside: -
Crinetics Pharmaceuticals
May 9, 2026
Rated: Buy
Price Target: $90 → $89
Current: $35.87
Upside: +148.12%